MicroRNAs in asthma: Potential therapeutic targets

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 1, 2013, Pages 66-72

  Greene, Catherine M ^a   Gaughan, Kevin P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

asthma; microRNA; therapeutics

Indexed keywords

INTERLEUKIN 13; MICRORNA; MICRORNA 126; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 21; MICRORNA 221;

ASTHMA; BRONCHUS HYPERREACTIVITY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; TH2 CELL;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHI; CELL PROLIFERATION; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871247957     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835a5bc8     Document Type: Review

References (37)

1. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summaryofthe GINA Dissemination Committee report. Allergy 2004; 59:469-478.
2. Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, healthcare use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012; 94:1-8.
3. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332:868-875.
4. Fang L, Deng Z, Shatseva T, et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011; 30:806-821.
5. Yu Z, Willmarth NE, Zhou J, et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 2010; 107:8231-8236.
6. Haussecker D, Kay MA. miR-122 continues to blaze the trail for microRNA therapeutics. Mol Ther 2010; 18:240-242.
7. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease: master regulators or target practice? Respir Res 2010; 11:148.
8. Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 2010; 184:1702-1709.
9. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-854.
10. Hassan T, McKiernan PJ, McElvaney NG, et al. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Expert Rev Anti Infect Ther 2012; 10:359-368.
11. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327:198-201.
12. Henry JC, Azevedo-Pouly AC, Schmittgen TD. MicroRNA replacement therapy for cancer. Pharm Res 2011; 28:3030-3042.
13. Garbacki N, Di Valentin E, Huynh-Thu VA, et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One 2011; 6:e16509.
14. Tsitsiou E, Williams AE, Moschos SA, et al. Transcriptome analysis shows activation of circulating CD8\+ T cells in patients with severe asthma. J Allergy Clin Immunol 2012; 129:95-103.
15. Mattes J, Collison A,Plank M,et al. Antagonismof microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 2009; 106:18704-18709.
16. Collison A, Herbert C, Siegle JS, et al. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med 2011; 11:29.
17. Polikepahad S, Knight JM, Naghavi AO, et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J Biol Chem 2010; 285:30139-30149.
18. Kumar M, Mabalirajan U, Agrawal A, et al. Proinflammatory role of let-7 miRNAs in experimental asthma? J Biol Chem 2010; 285:le19.
19. Kumar M, Ahmad T, Sharma A, et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol 2011; 128:1077-1085; e1-e10.
20. Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009; 182:4994-5002.
21. Lu TX, Hartner J, Lim EJ, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011; 187:3362-3373.
22. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141-147.
23. Zheng Y, Xiong S, Jiang P, et al. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel antiinflammation mechanism. Free Radic Biol Med 2012; 52:1307-1317.
24. Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011; 108:11193-11198.
25. Collison A, Mattes J, Plank M, et al. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol 2011; 128:160-167; e4.
26. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-12486.
27. Larner-Svensson HM, Williams AE, Tsitsiou E, et al. Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respir Res 2010; 11:68.
28. Feng MJ, Shi F,Qiu C, Peng WK. MicroRNA-181a,-146a and-146b inspleen CD4\+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol 2012; 13:347-353.
29. Sharma A, Kumar M, Ahmad T, et al. Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J Appl Physiol 2012; 113:459-464.
30. Qin HB, Xu B, Mei JJ, et al. Inhibition of miRNA-221 suppresses the airway inflammation in asthma. Inflammation 2012; 35:1595-1599.
31. Mayoral RJ, Deho L, Rusca N, et al. MiR-221 influences effector functions and actin cytoskeleton in mast cells. PLoS One 2011; 6:e26133.
32. Chiba Y, Tanabe M, Goto K, et al. Down-regulation of miR-133a contributes to up-regulation of RhoA in bronchial smooth muscle cells. Am J Respir Crit Care Med 2009; 180:713-719.
33. Chiba Y, Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci 2010; 114:264-268.
34. Kuhn AR, Schlauch K, Lao R, et al. MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2010; 42:506-513.
35. Tan Z, Randall G, Fan J, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007; 81:829-834.
36. Su XW, Yang Y, Lv ML, et al. Association between single-nucleotide polymorphisms inpremiRNAs and the risk ofasthma inaChinese population. DNA Cell Biol 2011; 30:919-923.
37. Jimenez-Morales S, Gamboa-Becerra R, Baca V, et al. MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients. Tissue Antigens 2012; 80:317-321. doi: 10.1111/j.1399-0039.2012.01929.x.